Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077181
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
2004-02-10
Brief Title:
3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Secondary Acute Myeloid Leukemia |
| Accelerated Phase Chronic Myelogenous Leukemia |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Blastic Phase Chronic Myelogenous Leukemia |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
| Relapsing Chronic Myelogenous Leukemia |
Keywords: